先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01302 先健科技

休市中 09-11 16:08:55

1.385

+0.035

+2.59%

最高1.400	最低1.330	成交量5,661万
今开1.340	昨收1.350	日振幅5.19%
总市值64.15亿	流通市值64.15亿	总股本46.32亿
成交额7,703万	换手率1.22%	流通股本46.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01302","market":"HK","secType":"STK","nameCN":"先健科技","latestPrice":1.385,"timestamp":1789114135002,"preClose":1.35,"halted":0,"volume":56606000,"delay":0,"changeRate":0.025925925925925866,"floatShares":4632000000,"shares":4632000000,"eps":0.03859854713191917,"marketStatus":"休市中","change":0.035,"latestTime":"09-11 16:08:55","open":1.34,"high":1.4,"low":1.33,"amount":77032640,"amplitude":0.051852,"askPrice":1.385,"askSize":32000,"bidPrice":1.38,"bidSize":296000,"shortable":3,"etf":0,"ttmEps":0.014213622568093385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":7,"adr":0,"listingDate":1320854400000,"exchange":"SEHK","adjPreClose":1.35,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":4.091921119592875,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01302/wiki","defaultTab":"wiki","newsList":[{"id":"1120002713","title":"先健科技2026年上半年营收6.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120002713","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120002713?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:42","pubTimestamp":1789116172,"startTime":"0","endTime":"0","summary":"先健科技2026年上半年实现营收6.01亿元，同比下降11.2%。毛利为4.66亿元，同比下降6.4%，毛利率由73.6%上升至77.5%。经营亏损为0.11亿元，上年同期为经营利润0.64亿元，同比下降117.5%。经营活动产生的现金净额为3.55亿元，上年同期为3.91亿元，同比下降9.2%。销售及分销开支为1.78亿元，同比减少28.9%；管理费用1.47亿元，同比增加24.3%；研发费用1.32亿元，同比增加15.5%。结构性心脏病业务方面，实现营收2.00亿元，同比下降26.3%，主要由于封堵器产品销售下滑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"先健科技2026年上半年营收6.01亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股异动 | 先健科技(01302)涨超3% LantvalTM主动脉瓣膜置换系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666517543?lang=zh_cn&edition=full","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上，先健科技发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","159883","LNGR","BK1100","PTH","BK1574","09996","BK1600","BK4585","01302","MEDX","BK4588","GDOC","IEIH","AGNG","MDEV","LGHT","HART","BK1583","VXUS","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：医疗器械板块业绩有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666127155?lang=zh_cn&edition=full","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1587","GDOC","BK1142","BK1161","601066","IEIH","BK1593","06826","HART","LGHT","MEDX","AGNG","BK1222","BK1571","BK1247","09996","01066","PTH","BK1583","BK1600","KCE","LNGR","BK1515","BK1574","02252","00241","BK1615","00853","02190","BK1591","HK0000165453.HKD","LU0173614495.USD","01302","BK1502","MDEV","RSPH","BK0276","LU0287142896.SGD","02235","BK1610","BK1617","BK1584","BK1189","BK1585","BK1589","BK1100","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555250","title":"先健科技：Lantval进入特别审查程序，系第十八个产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555250","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666555250?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:23","pubTimestamp":1788999786,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01302","BK1583","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555598","title":"先健科技(01302)：LantvalTM主动脉瓣膜置换系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555598","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666555598?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:06","pubTimestamp":1788998762,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技 发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","09996","MDEV","BK1574","IEIH","AGNG","BK1600","LGHT","PTH","MEDX","LNGR","BK1583","01302","159883","GDOC","RSPH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147258405","title":"先健科技（01302）旗下LantvalTM主动脉瓣膜置换系统获纳入国家药监局创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1147258405","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147258405?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:05","pubTimestamp":1788998733,"startTime":"0","endTime":"0","summary":"财经讯 2026年9月10日，先健科技 发布自愿性公告称，公司于2026年9月9日收到国家药品监督管理局的正式书面通知，确认由公司附属深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的“LantvalTM主动脉瓣膜置换系统”被纳入国家药品监督管理局创新医疗器械特别审查程序。公告显示，LantvalTM主动脉瓣膜置换系统适用于主动脉瓣狭窄或狭窄伴关闭不全患者，是全球首款全预装干式瓣膜设计的免缝合主动脉瓣膜置换产品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178236158","title":"先健科技8月股份变动月报，股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1178236158","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178236158?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:52","pubTimestamp":1788429132,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年9月3日发布截至2026年8月31日的股份变动月报。报告显示，公司注册股本仍为40,000,000,000股，面值每股USD 0.00000125，法定/注册股本总额继续维持USD 50,000。于本月底，公司已发行普通股4,631,712,400股，库藏股数量为0股，股份总数保持不变。本月内公司未进行新增股份发行、购回或注销操作。公司在公告中确认，所有发行及股份变动事宜均遵守香港联交所《上市规则》及相关法律法规的要求。随后，公司进一步重申已符合最低公众持股量规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097621","title":"先健科技公布2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097621","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663097621?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:31","pubTimestamp":1787927460,"startTime":"0","endTime":"0","summary":"深圳2026年8月28日 /美通社/ -- 2026年8月28日，领先的心脑血管及外周血管介入医疗器械企业——先健科技公司及其附属公司公布截至2026年6月30日止六个月的未经审核综合业绩。于报告期内，本集团结构性心脏病业务贡献的销售额约为人民币200.1百万元。本集团持续重视高质量的全球知识产权布局，截至2026年6月30日累计提交2,608项有效专利申请，其中1,370项已获批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5035983_ZH35983_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5035983_ZH35983_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1583","01302","BK1100","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056401","title":"先健科技上半年净利润同比降51.9%至约1.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056401","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662056401?lang=zh_cn&edition=full","pubTime":"2026-08-28 13:02","pubTimestamp":1787893320,"startTime":"0","endTime":"0","summary":"8月28日，先健科技（01302）发布截至2026年6月30日止六个月的业绩。收益约为6.01亿元，较截至2025年同期的收益约6.77亿元减少约11.2%。毛利约为4.66亿元，较2025年同期的毛利约4.98亿元减少约6.4%。剔除非经常性项目后，本公司拥有者应占纯利由2025年同期的约2.39亿元减少约51.9%至约1.15亿元，主要由于收益减少和汇兑收益净额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283857986856.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283857986856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662605520","title":"先健科技(01302.HK)发布中期业绩，股东应占亏损3434.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662605520","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662605520?lang=zh_cn&edition=full","pubTime":"2026-08-28 12:33","pubTimestamp":1787891618,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01302","BK1583","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659218779","title":"港股异动 | 先健科技(01302.HK)跌超3% 中期纯利预降约50%至54% 收入下降及汇兑收益减少拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218779","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659218779?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:21","pubTimestamp":1786591285,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01302","BK1100","BK1600","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970046","title":"先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970046","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658970046?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:19","pubTimestamp":1786540753,"startTime":"0","endTime":"0","summary":"该等非经常性项目包括以股份为基础的付款开支、按公平值计入损益的金融资产的其他损益及与涉及董事会已决议不予推进的北京华医圣杰科技有限公司股权收购及发行可换股债券的主要交易有关的预期交易费用。考虑该等非经常性项目的影响，集团预期截至2026年6月30日止六个月将取得公司拥有人应占亏损介于人民币3000万元至4000万元之间，而2025年同期取得公司拥有人应占纯利约人民币5510万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"先健科技(01302)发盈警 预计上半年股东应占亏损3000万元至4000万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165318899","title":"先健科技：预计2026年上半年归母净利润达1.1亿至1.2亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1165318899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165318899?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:12","pubTimestamp":1786540369,"startTime":"0","endTime":"0","summary":"先健科技（LIFETECH SCI）发布业绩预告，预期截至2026年6月30日止六个月的归属于公司所有者的净利润将落在人民币1.1亿元至1.2亿元区间内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","01302","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166287078","title":"先健科技（01302）发盈利预警：2026年上半年扣除非经常性项目后预盈1.1亿至1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166287078","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166287078?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:11","pubTimestamp":1786540281,"startTime":"0","endTime":"0","summary":"2026年8月12日，先健科技发布盈利预警称，依据截至2026年6月30日止六个月的未经审计综合管理账目及董事会初步评估，若剔除若干非经常性项目影响，预计期内录得本公司拥有人应占纯利约人民币1.1亿元至1.2亿元；而2025年同期录得纯利约人民币2.385亿元。公司计划于2026年8月底前公布截至2026年6月30日止六个月的中期业绩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097058","title":"先健科技(01302)：方宇获委任为授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097058","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097058?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:56","pubTimestamp":1786539413,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技(01302)发布公告，执行董事方宇先生已获委任为香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表，自2026年8月12日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1583","01302","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146608101","title":"先健科技（01302）委任方宇为上市规则3.05条下公司授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=1146608101","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146608101?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:55","pubTimestamp":1786539333,"startTime":"0","endTime":"0","summary":"2026年8月12日，先健科技（01302）公告称，公司执行董事方宇已获董事会委任为香港联合交易所有限公司证券上市规则3.05条项下的公司授权代表，任命自2026年8月12日起生效。\n公告显示，方宇的加入后，公司在上市规则3.05条项下的授权代表将由谢粤辉与方宇共同担任。该任命与2026年5月22日公布的刘剑雄先生辞任执行董事及授权代表的事项衔接。\n截至本公告日期，先健科技董事会成员包括：执行董事谢粤辉，独立非执行董事吴丽萍、方宇、陈东霞、姜峰及周路明。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199226420","title":"先健科技（01302）拟于8月28日召开董事会 审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1199226420","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199226420?lang=zh_cn&edition=full","pubTime":"2026-08-12 19:31","pubTimestamp":1786534286,"startTime":"0","endTime":"0","summary":"本报讯 先健科技（01302）8月12日公告称，公司董事会已定于2026年8月28日（星期五）召开会议，主要议程包括：\n1. 审议并批准先健科技及其附属公司截至2026年6月30日止六个月的未经审核中期业绩，并通过在香港交易及结算所有限公司及公司官网刊登相关业绩公告；\n2. 研究及决定是否派发中期股息；\n3. （如有需要）审议暂时停止办理公司股份过户登记手续；\n4. 处理其他相关事项。\n本次董事会由执行董事、董事会主席兼首席执行官谢粤辉先生召集。董事会现任成员包括执行董事谢粤辉先生、吴丽萍女士及方宇先生；以及独立非执行董事周路明先生、陈东霞女士及姜峰先生。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107144595","title":"先健科技2026年7月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107144595","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107144595?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:41","pubTimestamp":1785832889,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年8月4日发布2026年7月股份变动月报表。公告显示，公司在2026年7月并未进行任何新股发行、股份购回或股票注销，整个报告期内股本总数保持稳定。报告期末，已发行股份总数为4,631,712,400股，库藏股为0股，分别与上月末持平。股权激励方面，公司于报告期内并无因行使股票期权而新增发行股份，月内行权产生资金金额为0港元。公司在公告中确认其已符合适用的公众持股量要求，并承诺遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176798974","title":"先健科技(01302)宣布终止收购华医股权及发行可换股债券计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1176798974","media":"公告速递","labels":["executive","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176798974?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:13","pubTimestamp":1784545981,"startTime":"0","endTime":"0","summary":"香港，2026年7月20日，先健科技有限公司发布公告称，公司董事会已决定不再推进此前拟议的收购华医股权及根据特别授权发行可换股债券的主要交易。公告显示，先健科技与卖方就股权购买协议及可换股债券票据等最终交易文件已进行谈判，但双方迄今未能达成一致。基于审慎考虑并为消除潜在不确定因素，董事会决定终止交易；相关的可换股债券发行及特别授权事项亦将不再进行，公司亦不会就此向股东寄发通函或召开股东特别大会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100235998","title":"先健科技公告重大交易：拟收购星途股权并发行可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=1100235998","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100235998?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:52","pubTimestamp":1784544763,"startTime":"0","endTime":"0","summary":"先健科技宣布一项重大交易，涉及拟收购星途股权以及计划发行可转换债券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1100","BK1600","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifetechmed.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.1234},{"period":"6month","weight":-0.204},{"period":"1year","weight":-0.2749},{"period":"ytd","weight":-0.1122}],"compareEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0035},{"period":"6month","weight":-0.0259},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0322}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.025079},{"month":2,"riseRate":0.384615,"avgChangeRate":0.028221},{"month":3,"riseRate":0.615385,"avgChangeRate":0.017514},{"month":4,"riseRate":0.538462,"avgChangeRate":0.025302},{"month":5,"riseRate":0.538462,"avgChangeRate":0.072446},{"month":6,"riseRate":0.538462,"avgChangeRate":0.041537},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.056658},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.051457},{"month":9,"riseRate":0.615385,"avgChangeRate":0.030165},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004062},{"month":11,"riseRate":0.416667,"avgChangeRate":0.043537},{"month":12,"riseRate":0.384615,"avgChangeRate":0.000564}],"exchange":"SEHK","name":"先健科技","nameEN":"LIFETECH SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先健科技,01302,先健科技股票,先健科技股票老虎,先健科技股票老虎国际,先健科技行情,先健科技股票行情,先健科技股价,先健科技股市,先健科技股票价格,先健科技股票交易,先健科技股票购买,先健科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}